InflaRx N.V. carries a market capitalization of 129.91M, placing it among publicly traded companies globally. Its enterprise value stands at -56.99M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 129.91M |
| Enterprise Value | -56.99M |
InflaRx N.V. currently has 58.88M shares outstanding.
| Shares Outstanding | 58.88M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
InflaRx N.V. maintains a current ratio of 5.31, meaning it holds 5.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.38, indicating moderate leverage, while an interest coverage ratio of -1,453.82 demonstrates limited ability to service its debt obligations.
| Current Ratio | 5.31 |
| Quick Ratio | 4.34 |
| Debt / Equity | 1.38 |
| Debt / EBITDA | -0.02 |
| Interest Coverage | -1,453.82 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -54.39 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.14 |
| Income Tax | 5,217.00 |
| Effective Tax Rate | N/A |
InflaRx N.V.'s stock has gained approximately 1.27498% over the past 52 weeks. The 50-day moving average sits at 1.69, while the 200-day moving average is 2.50.
| Beta (5Y) | N/A |
| 52-Week Price Change | 1.27498% |
| 50-Day Moving Average | 1.69 |
| 200-Day Moving Average | 2.50 |
| Average Volume (20 Days) | N/A |
EBITDA reached -56.04M, while operating income came in at -56.55M.
| Revenue | 168,499.00 |
| Gross Profit | -604,766.00 |
| Operating Income | -56.55M |
| Pretax Income | -56.88M |
| Net Income | -56.88M |
| EBITDA | -56.04M |
| EBIT | -56.55M |
| Earnings Per Share (EPS) | N/A |
InflaRx N.V. holds 57.89M in cash and equivalents against 897,907.00 in total debt, resulting in a net debt position of -26.21M. Total book value stands at -320.01M, with working capital of 59.75M providing operational flexibility.
| Cash & Cash Equivalents | 57.89M |
| Total Debt | 897,907.00 |
| Net Debt | -26.21M |
| Equity (Book Value) | -320.01M |
| Book Value Per Share | N/A |
| Working Capital | 59.75M |
InflaRx N.V. produced -47.54M in operating cash flow over the past twelve months.
| Operating Cash Flow | -47.54M |
| Capital Expenditures | -65,150.00 |
| Free Cash Flow | -47.60M |
| FCF Per Share | N/A |
InflaRx N.V. operates with a gross margin of -358.91, reflecting its pricing power and cost economics. The operating margin of -33,562.00 and net profit margin of -33,758.53 provide insight into operational efficiency.
| Gross Margin | -358.91 |
| Operating Margin | -33,562.00 |
| Pretax Margin | -33,755.43 |
| Profit Margin | -33,758.53 |
| EBITDA Margin | -33,259.38 |
InflaRx N.V. posts an Altman Z-Score of -7.19, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -7.19 |